<DOC>
	<DOC>NCT00193700</DOC>
	<brief_summary>Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in the extension part (UMD-01-080E).</brief_summary>
	<brief_title>Pharmacokinetic Evaluation of Testosterone Gel (1%)</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Diagnosis of primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP) Clinically significant uncontrolled medical condition or psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Hypogonadism</keyword>
</DOC>